Cargando…

Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis

BACKGROUND: The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials constrain a plans gradient index. The purpose of this work is to describe the depend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, David, Dragojević, Irena, Hoisak, Jeremy, Hoopes, David, Manger, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724320/ https://www.ncbi.nlm.nih.gov/pubmed/31481089 http://dx.doi.org/10.1186/s13014-019-1334-9

Ejemplares similares

On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
por: Leung, Ronnie Wing King, et al.
Publicado: (2020)

Assessing the performance of an automated breast treatment planning software
por: Dragojević, Irena, et al.
Publicado: (2021)

An analytical expression for R50% dependent on PTV surface area and volume: a lung SBRT comparison
por: Desai, Dharmin D., et al.
Publicado: (2020)

Reducing PTV margins for prostate SBRT with motion compensation and gating techniques
por: Goddard, Lee, et al.
Publicado: (2022)

Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
por: Moiseenko, Vitali, et al.
Publicado: (2020)

4DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm
por: Li, Yi, et al.
Publicado: (2016)

A physically meaningful relationship between R50% and PTV surface area in lung SBRT
por: Desai, Dharmin D., et al.
Publicado: (2020)

Target repositional accuracy and PTV margin verification using three‐dimensional cone‐beam computed tomography (CBCT) in stereotactic body radiotherapy (SBRT) of lung cancers
por: Wang, Lu, et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease
por: Reshko, Leonid B., et al.
Publicado: (2021)

New target volume delineation and PTV strategies to further personalise radiotherapy
por: Bernstein, David, et al.
Publicado: (2021)

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
por: Voglhuber, Theresa, et al.
Publicado: (2020)

Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT)
por: Dupic, Guillaume, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans
por: Trémolières, Pierre, et al.
Publicado: (2022)

Improved biological dosimetric margin model for different PTV margins with stereotactic body radiation therapy in homogeneous and nonhomogeneous tumor regions
por: Kawahara, Daisuke, et al.
Publicado: (2022)

Dose fall-off during the treatment of thoracic spine metastasis with CyberKnife stereotactic body radiation therapy (SBRT)
por: Ju, Zhongjian, et al.
Publicado: (2020)

Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
por: Reyngold, Marsha, et al.
Publicado: (2013)

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
por: Gurka, Marie K, et al.
Publicado: (2015)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
por: Gerum, Sabine, et al.
Publicado: (2018)

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
por: Sogono, Paolo, et al.
Publicado: (2021)

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
por: Nikitas, John, et al.
Publicado: (2019)

Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients
por: Meng, Yinnan, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
por: Chen, Leonard N, et al.
Publicado: (2013)

Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations
por: Herman, Tania De La Fuente, et al.
Publicado: (2010)

Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Primary Lung Cancer in Recipients of Lung Transplant
por: Moore, Assaf, et al.
Publicado: (2020)

Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
por: Chai, Guangjin, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial
por: Paronetto, Chiara, et al.
Publicado: (2023)

PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
por: Lockney, Natalie A., et al.
Publicado: (2017)

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China
por: Zhao, Xianzhi, et al.
Publicado: (2020)

How Does the Gradient Measure of the Lung SBRT Treatment Plan Depend on the Tumor Volume and Shape?
por: Duan, Yanhua, et al.
Publicado: (2021)

Technical Note: Comparison of the internal target volume (ITV) contours and dose calculations on 4DCT, average CBCT, and 4DCBCT imaging for lung stereotactic body radiation therapy (SBRT)
por: Dumas, Michael, et al.
Publicado: (2020)

Dose prescription with spatial uncertainty for peripheral lung SBRT
por: Bedford, James L., et al.
Publicado: (2018)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
por: Badloe, Justine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d9u9nabgrsc25rcpt5ceo8fhua